Progress and Perspectives in Allogeneic Cell‐Based Pulp Regeneration
Despite encouraging preliminary results, significant limitations remain in the establishment of standardised protocols and the development of reliable techniques for longitudinal cell tracking. In future research, optimised delivery systems, immune-evasive cell engineering and rigorous clinical trial designs should be optimised to advance REPs towards predictable, clinically viable therapies.
Authors
- Leyi Chen (ORCID: https://orcid.org/0000-0002-7090-3788)
- Jianguang Xu (ORCID: https://orcid.org/0000-0001-8773-1241)
- Lee Yan Lam (ORCID: https://orcid.org/0009-0006-9479-8579)
- Y. Y. Chen (ORCID: https://orcid.org/0009-0007-3156-4713)
- Xin Li (ORCID: https://orcid.org/0000-0002-6979-1037)
- Yuchen Zhang (ORCID: https://orcid.org/0000-0003-3572-9830)
- Shulan Lin
- Mingxin Hu (ORCID: https://orcid.org/0000-0001-6757-9780)
Institutions
- Anhui Medical University (CN)
- Stomatology Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- International Endodontic Journal
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1111/iej.70080
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00